Technology Development AgreementTechnology Development Agreement • July 18th, 2011 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Party A entrusts Party B to develop Qunle Xuyuan Tablet (Tentative) and apply for registration on behalf of Party A. With the function of improving hypoxia tolerance, Qunle Xuyuan Tablet is made from Ginkgo Leaf, Gynostemma Pentaphyllum, Puerariae Extract, Panax Quinquefolius, Mint, Cinnamomum Cassia and Amomum Cardamomum etc. Party A shall pay Party B fees and compensations incurred during technology development and registration. Party B accepts the contract and shall undertake to conduct the technology development and apply for registration. Based on mutual negotiation, the parties hereby enter into this agreement (“Agreement”) according to People’s Republic of China Contract Law. Both parties shall abide by the terms in this Agreement.
Technology Development AgreementTechnology Development Agreement • July 18th, 2011 • China Health Industries Holdings, Inc. • Pharmaceutical preparations
Party A entrusts Party B to develop and register the Xinyan 28 Package (Tentative), a skincare product with whitening, moisturizing and anti-aging effect. Party A shall pay Party B fees and compensations incurred during technology development and registration. Party B accepts the contract and shall undertake to conduct the technology development and apply for registration. Based on mutual negotiation, the parties hereby enter into this agreement (“Agreement”) according to People’s Republic of China Contract Law. Both parties shall abide by the terms in this Agreement.
